← Back to IONS

Ionis Pharmaceuticals, Inc. - Common Stock financial statements

Annual and standalone quarterly facts filed by the company with the SEC. Monetary values are shown in USD millions; per-share values use USD.

Filed statements

USD; millions except EPSJun 2026Filed 29/07/2026Mar 2026Filed 29/04/2026Dec 2025Filed 26/02/2026Sep 2025Filed 29/10/2025Jun 2025Filed 29/07/2026Mar 2025Filed 29/04/2026Dec 2024Filed 26/02/2026Sep 2024Filed 29/10/2025
$268$246$203$157$452$132$227$134
−$115−$93−$229−$129$124−$147−$104−$140
−$0.69−$0.56−$1.41−$0.80$0.70−$0.93−$0.66−$0.95
165165160182159149

Trend

Revenue

Source: SEC EDGAR Company Facts. Values are normalized from issuer-filed US GAAP or IFRS XBRL facts. Missing cells stay missing; cumulative interim cash flows are not converted into estimated quarters.